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ABSTRACT
With dependence upon opioids, such as codeine, morphine, and heroin, steadily
increasing amongst the American public, the withdrawal symptoms associated with disuse are
receiving much more attention. Our research identifies neurons that are implicated in the
hyperanalgesic response to the cessation of opiate-medication after dependence has been
established. These neurons are identified by the Cholecystokinin protein (CCK). The first chapter
of this research focuses on localizing these neurons in regions of the central nervous system that
are responsible for transducing painful signals from the periphery to the brain. Our research
supports the hypothesis that neurons with high levels of CCK expression (CCK(+) neurons) are
involved in the transmission of pain from the periphery to the brain. We did not find that the
CCK(+) neurons communicate through GABA neurotransmission.
The second chapter of this research focuses on an experimental observation that CCK
expression was localized in the vasculature of the spinal cord, but not cortical tissue. Lipophilic
vasculature staining through the use of DiI provided contrary results, and indications that CCKexpression may be capillary-dependent.
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INTRODUCTION
Rationale
With incidences of opioid-dependence steadily increasing amongst the American public,
the withdrawal symptoms associated with disuse are receiving much more attention [1]. From
regular appearances in pop culture songs to the underlying theme in many independent films,
opioid addiction and withdrawal have become common conflicts that Americans are exposed to
in everyday life. Opioid-dependence has increased in-tandem with opioid-prescription rates, and
it’s only right that research into the complicated processes of addiction and withdrawal keep up.
Unfortunately, scientific understanding of the complex actions of opioid painkillers and
the implications of chronic use are lacking. This research project aims to identify particular
neurons that are involved with the withdrawal symptoms of opioid-dependence. More
specifically, this research aims to localize neurons in the sensory pathways that express
cholecystokinin (CCK), a protein that has been implicated in the regulation of opiate-mediated
pain transmission [2]. By locating the distribution of these neurons throughout the central nervous
system, and then beginning to characterize their function, we aim to provide insight into the
biological mechanism(s) responsible for the regulation of opiate-mediated analgesia. These
findings may serve to undermine high levels of opioid prescriptions, or suggest alternative drug
therapies for combating pain pathologies.
Previous Research into the Role of CCK
Cholecystokinin (CCK) is an enzyme that was first identified in the duodenum (small
intestine) of mammals. In the gut, CCK plays a role in signaling the release of bile from the
gallbladder and digestive enzymes from the pancreas [3]. In this way, CCK acts as a precursor to
the breakdown of fat and protein. Recent evidence indicates that CCK also plays a role in the
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experience of painful sensations. Such research implicates neurons that express CCK (hereon
termed CCK(+) neurons) in the sensation of hyperalgesia in response to the acute discontinuation
of opiate medication[2]. Inversely, while using opiate medication, CCK may be involved in
depressing the effects of opiate-induced analgesia, leading patients to require larger and larger
doses to alleviate the same level of pain.
Anatomy/Physiology
The central nervous system (CNS), consisting of the brain and spinal cord, plays a
necessary role in making sure that exposure to pain is perceived correctly. In order to do so, the
CNS is organized in a very particular manner. The ventral, or motor, portion of the spinal cord is
home to the neurons that are responsible for controlling our muscles. The dorsal, or sensory,
portion of the spinal cord receives information from the periphery and transmits it to the brain in
order to perceive it [4]. However, the spinal cord is limited in that it only receives information
from below the neck.
In order to perceive information from the neck and above, we rely on the sensory nucleus
of cranial nerve 5, also known as the sensory region of the trigeminal nucleus. The trigeminal
nucleus is a cluster of neurons located in the brainstem, which is organized from medial to
lateral. The sensory areas of the brainstem are found most lateral [5]. Thus, sensory information
from the neck, face, and head (including pain) must be transmitted through the outermost cell
bodies of the trigeminal nucleus.
Neuronal Communication
Neurons in the body communicate through the use of neurotransmitters.
Neurotransmitters are chemical compounds that are transmitted from one neuron to another; in
this way, information is passed throughout the nervous system [6]. CCK(+) neurons in the CNS
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belong to one of two main subcategories: glutamatergic or GABAergic, depending on which
neurotransmitter they use to relay information [7][8]. Although neurotransmitters may have
different actions depending on their location, this experiment targets glutamate and GABA
because they are highly abundant and highly specific. A neurotransmitter will either be
excitatory, like glutamate, or inhibitory, like GABA. Excitatory neurotransmitters increase the
likelihood that a neuron will generate an action potential and propagate a signal. Inhibitory
neurotransmitters decrease the likelihood of signal propagation. Glutamate is the most common
excitatory neurotransmitter in the CNS, while GABA is the most common inhibitory
neurotransmitter in the CNS [9].
Research Objectives
The goal of this research experiment is to localize CCK(+) cell bodies within the sensory
pathways and categorize them as either glutamatergic or GABAergic. In order to localize these
neurons, genetically-modified mice (CCK-TdTomato) were bred. Neuronal tissue from these
mice was stained with various immunohistochemical reagents and analyzed through confocal
microscopy.
After the CCK(+) neurons had been localized, antibody staining techniques indicated the
presence or absence of the GABA neurotransmitter. Successful acquisition of this information
will provide data for future studies into the biological and electrical properties of these neurons,
and thus inspire insight into the behavioral implications involved in the sensation of pain.
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RESEARCH QUESTION
Are CCK(+) neurons in the spinal cord and trigeminal nucleus involved in the transmission of
pain? What biological mechanisms do CCK(+) neurons use to communicate and modulate the
pain pathway?
MATERIALS & METHODS
Reagents
•   Isoflurane (B72J15B, Piramal)
•   Euthasol (200-071, Virbac)
•   PBS (P3813, Sigma-Aldrich)
•   Paraformaldehyde (HT501128-4L, Sigma-Aldrich)
•   SeaPlaque Brain Slice Agar (100262, MP Biomedicals)
•   Low Melting Point Agarose (50101, Lonza)
•   TEA Buffer (1610773, BioRad)
•   Aluminum Foil (obtained at retail store)
•   AAA Battery (obtained at retail store)
•   Superglue (obtained at retail store)
•   Triton X-100 (T8787, Sigma-Aldrich)
•   SYTO 13 Immunohistochemical Stain (S7575, ThermoFisher)
•   Bovine Syrum Albumin (BSA) (A9647-50G, Sigma-Aldrich)
•   Anti-GAD65/67 Primary Antibody (PA1-84572, ThermoFisher)
•   Anti-GABA Primary Antibody (AB175, Sigma-Aldrich)
•   Goat Anti-Mouse Secondary Antibody (A32723, ThermoFisher)
•   Donkey Anti-Rabbit Secondary Antibody (A-21206, ThermoFisher)
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•   Vectashield Mounting Medium for Fluorescence (H-1400, Vector Laboratories)
•   Clear nail polish (obtained at retail store)
Equipment
•   26 ½ Gauge Needles
•   Mini-Pump Variable Flow Perfusion Device (Fisher Scientific)
•   Dissection Equipment
•   Plexi-glass Chamber
•   Three-way stopcocks
•   50mL conical tubes
•   12-well plate
•   Soft-tip Paintbrush
•   Microscope slides
•   Standard glass coverslips (no. 1.5)
•   Vibratome (VT1000s, Leica)
•   Confocal Microscope (LSM 510 Meta, Zeiss)

REAGENT SETUP
2% Brain Slice Agarose
Add .4g Brain slice agar to 20mL of 1x TAE Buffer. Pour into petri dish. Store at 4 °C.

2% Low Melting Agarose
Use microwave to dissolve 0.2g in 10ml 1x TAE Buffer. Cool at RT and use immediately.
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0.2% PBT
Mix 1mL Triton X-100 detergent with 500mL of PBS solution. Store at Room Temperature.

SYTO 13 Work Solution
Dilute 5mM stock 1:10 in PBT.

5% BSA Work Solution (for 12 wells)
Dissolve 0.3g of BSA stock in 6mL of 0.2% PBT.

PROCEDURES
Cardiac Perfusion
1.   In ice bucket, cool PBS and PFA in separate 50mL conical tubes
2.   Fill mini-pump tubes with respective liquid; ensure no air is in lines
3.   Saturate plexi-glass chamber with Isoflurane
a.   Wet tissue paper in 50mL conical tube with Isoflurane and place in chamber
4.   Prepare syringe with Euthasol
a.   .05mL for female mice; .07mL for male mice
5.   Place mouse in Isoflurane chamber until breathing is slow
6.   Remove mouse by grasping the neck fur; place on lab mat and check paw reflex by
pinching any of the paws
a.   If the animal reacts, anesthetize further; if not, proceed.
7.   Inject the mouse intraperitoneal with Euthasol and place on dissecting tray; hold the
mouse in place with its tail until euthanasia has occurred
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8.   Pin the mouse through its four paws, leaving the thoracic cavity exposed
9.   Open the thoracic cavity to expose the heart by first cutting through the skin, then
through the viscera
10.  Pull ribcage back and ensure the heart is fully accessible
11.  Insert 26 ½ gauge needle into the left ventricle while supporting with hemostat; once
punctured, clamp with hemostat
12.  Cut right atrium with scissors and begin perfusion (at slowest possible rate)
13.  Perfuse with cold PBS until perfusate runs clear (at least 10 minutes)
a.   Intestines and liver will turn a clear color, indicating a successful perfusion
14.  Switch to cold 4% PFA and perfuse for 10 minutes, then switch back to PBS for 10
minutes
15.  Collect brain and spinal cord tissue and place in 4% PFA overnight at 4 °C to complete
fixation
16.  Dispose of mouse accordingly
Spinal Cord Prep for Slicing
1.   Tear off thin strip of aluminum foil approx. 4 inches long
2.   Roll aluminum foil around AAA battery, leaving positive terminal exposed
a.   Fold foil around the bottom of the battery and press against lab bench to ensure a
closed bottom
3.   Remove battery from foil; fill foil cylinder with 2% low melting agarose, leaving approx.
1cm for displacement
4.   Using forceps, embed spinal cord lengthwise in liquid agarose and allow to cool,
ensuring the tissue remains upright and parallel to cylinder walls
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Tissue Slicing
1.   Prepare Vibratome with PFA well
2.   Soak razorblade in ethanol for 2 minutes
3.   Using forceps, evenly attach blade to PFA-specific mount and screw into place
4.   Cut brain slice agarose into two rectangles, mounting a base and backbone to secure
animal tissue in Vibratome well
a.   Mount with the minimum amount of superglue to ensure agarose is in place, but
not overly saturated
5.   Prepare tissue for sectioning
a.   Trim brain with razor to ensure a flat surface for mounting
b.   Remove agarose-embedded spinal cord and ensure a flat surface for mounting
6.   Place a conservative amount of superglue on top of the base piece of agarose
7.   Using a spatula, add brain or spinal cord flush with the back piece of agarose, directly
centered on base agarose
8.   Fill well to the brim with PBS, making sure the blade and tissue are submerged
9.   Set the Vibratome to 100µm per slice
10.  Move blade close to the top of the tissue, set start position
11.  Slice through the top of the tissue, setting the endpoint within the back piece of agarose
12.  Hit the start button to automatically slice 100 microns below last cut
13.  Save desired slices in 12-well plate with 1mL of PBS in each well
a.   Add slices to wells using soft-tip paintbrush
i.   Approx. 3-4 brain slices per well
ii.   Approx. 4-5 spinal cord slices per well
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SYTO 13 Staining
All washes are 10 minutes long with 1mL of wash per well; washes and incubation take place on
rotor at low speed (constant agitation)
1.   Wash slices 2 times with 1mL 0.2% PBT
a.   Washes are done by discarding liquid into waste and adding 1mL of wash
b.   Always cover the 12-well plate with aluminum foil to prevent light exposure
2.   After second wash, remove remaining PBT
3.   Add 500µL 0.2% PBT
4.   Add SYTO 13 work solution, allowing for 500nM final concentration
5.   Incubate for 1 hour at room temperature
6.   Wash 3 times with 0.2% PBT
7.   Mount slices on microscope slides
Immunohistochemical Staining Protocol
All washes are 10 minutes long with 1mL of wash per well; washes, incubations, and washes
take place on rotor at low speed (constant agitation)
1.   Add 1mL of PBS to each well of a 12-well plate
2.   With soft-tip paintbrush, gently add tissue slices to wells and sink to the bottom
3.   Wash slices 1 time in PBS and 2 times in 0.2% PBT
4.   Block for 2 hours at room temperature in 1mL 5% BSA/PBT per well
a.   5% BSA/PBT made by dissolving .6g BSA in 12mL of 0.2% PBT
5.   Leave slices in blocking buffer overnight at 4 °C with constant agitation
a.   Using a moist Kimwipe and Parafilm, create a humidity chamber by taping the
Kimwipe to the roof of the 12-well plate and ensuring a good seal
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6.   After 36 hours, remove 12-well plate from cold room
7.   Wash slices 3 times in PBT
8.   Add 500 µL 5% BSA/PBT per well
9.   Add primary antibody at room temperature and block for 1 hour
a.   1µL per well for Anti-GABA (~1:500 dilution)
b.   2.5µL per well for Anti-GAD65/67 (~1:200 dilution)
10.  Leave primary antibody on shaker at 4 °C for 36 hours
a.   Create humidity chamber
11.  Wash 3 times in 0.2% PBT
12.  Add 500µL 0.2% PBT per wel
13.  Add 2.5µL of secondary antibody per well (~1:200 dilution)
a.   Goat Anti-Mouse for Anti-GABA
b.   Donkey Anti-Rabbit for Anti-GAD65/67
14.  Leave at room temperature for 3 hours with constant agitation
15.  Wash 3 times 0.2% PBT; 1 time PBS
16.  Mount slices on microscope slides
Microscope Mounting
1.   After mounting slices with soft-tip paintbrush, remove excess PBS from slide with
Kimwipe
2.   Add Vectashield drop-wise to ensure all tissue slices are protected from fading
3.   Mount coverslip and label slide
4.   Wrap in aluminum foil to protect from light exposure
5.   Store at 4 °C for 30 minutes
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6.   Cover edges of coverslip with a thin layer of clear nail polish to increase adhesion and
protect tissue from dehydration
7.   Store at 4 °C in black box to prevent light exposure
Confocal Microscopy
1.   Setup LSM 510 Meta microscope for multi-channel imaging
a.   For SYTO 13 collection, use 488nm excitation and collect using BP 505-530
filter
b.   For TdTomato collection, use 543nm excitation and collect using LP 560
2.   Use on-screen command to select the desired objective
3.   Set pinholes for each channel to 1
4.   Isolate area of interest in the optical objective
5.   Select ‘Find’, to collect an image
a.   adjust offset/gain as needed
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RESULTS
Through the use of confocal microscopy, the presence of CCK(+) neurons in the sensory
areas of the spinal cord and trigeminal nucleus were identified (Figure 1). Three regions of the
spinal cord were examined: the lumbar, thoracic, and cervical (Figure 2). Individual slices from
the cervical, thoracic, and lumbar spinal sections demonstrated strong red fluorescence
(TdTomato) in the dorsal region of the spinal cord. Slices stained with SYTO 13 also
demonstrated bright green fluorescence throughout all of the gray matter. 630x magnification of
these slices indicate an overlap of the red/green fluorescence (as indicated by a yellow/orange
color) in the dorsal areas of the sensory regions, specifically lamina II/III (Figure 1).
The SYTO 13 stain of the trigeminal nucleus resulted in a large yellow/orange
fluorescence in the lateral region of the brainstem. Slices from the rostral region of the trigeminal
nucleus showed an increased amount of yellow/orange fluorescence compared to the caudal
slices.
Anti-GAD65/67 and Anti-GABA immunostains, which fluoresce bright green,
demonstrated fluorescence throughout the gray and white matter of both the spinal cord and
trigeminal nucleus (Figure 3) (Figure 4). Primary and secondary antibody staining of both the
spinal cord and trigeminal nucleus slices showed many red fluorescent neurons, fewer
yellow/orange fluorescent neurons, and very little green fluorescent neurons.
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Figure 1. (Top) TdTomato co-localizes with SYTO 13 in the spinal cord.
(Left) A 5x image of the cervical spinal cord. (Right) A 20x magnified image of the dorsal region of the
cervical spinal cord showing (L) SYTO 13 fluorescence indicating the presence of neuronal cell bodies;
(M) TdTomato fluorescence indicating the presence of CCK; (R) A composite image indicating the colocalization of TdTomato and SYTO 13. CCK(+) cell bodies are identified by a yellow fluorescence.
(Bottom) TdTomato	
  co-‐localizes	
  with	
  S YTO	
  13	
  in	
  the	
  trigeminal	
  nucleus.	
  (Left)	
  A	
  5x	
  image	
  of	
  
the	
  rostral	
  trigeminal	
  nucleus.	
  ( Right)	
  A	
  20x	
  magnified	
  image	
  of	
  the	
  lateral	
  region	
  of	
  the	
  trigeminal	
  
nucleus	
  showing	
  (L)	
  SYTO	
  13	
  fluorescence	
  indicating	
  the	
  presence	
  of	
  n euronal	
  cell	
  bodies;	
  ( M)	
  
TdTomato	
  fluorescence	
  indicating	
  the	
  presence	
  of	
  CCK;	
  (R)	
  A	
  composite	
  image	
  indicating	
  the	
  co-‐
localization	
  of	
  TdTomato	
  and	
  SYTO	
  13.	
  

	
  	
  
	
  
	
  
	
  
	
  
	
  

	
  

13	
  

	
  
	
  
	
  
	
  
	
  

A

B

C

Figure 2. The spinal cord of a mouse separated into distinct regions:
(A)Cervical
(B)Thoracic
(C)Lumbar
(Top) 5x cervical spinal cord.
(Middle) 5x thoracic spinal cord.
(Bottom) 5x lumbar spinal cord.
All sections have been stained with SYTO 13 to identify neuronal cell bodies.
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Figure 3. Presence of the GABA neurotransmitter in the spinal cord.
(Top) Anti-GABA IHC stain showing (L) Anti-GABA; (M) TdTomato; (R) Composite
(Bottom) Anti-GAD 65/67 IHC stain showing (L) Anti-GAD 65/67; (M) TdTomato; (R) Composite
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Figure 4. Presence of the GABA neurotransmitter in the Trigeminal Nucleus.
(Top) Anti-GABA IHC stain showing (L) Anti-GABA; (M) TdTomato; (R) Composite
(Bottom) Anti-GAD 65/67 IHC stain showing (L) Anti-GAD 65/67; (M) TdTomato; (R) Composite
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DISCUSSION
Localization of CCK in the Sensory Pathways
As hypothesized, confocal analysis of the spinal cord shows extensive red/green
(TdTomato/SYTO 13) co-localization in the dorsal horn of the gray matter, indicating the
presence of CCK(+) cell bodies. This region of the spinal cord, particularly Lamina I/II, houses
the sensory neurons responsible for transducing signals of painful information from the periphery
to the brain. Interestingly, CCK expression was very well conserved throughout the different
regions of the spinal cord, suggesting its importance in the role of peripheral pain transduction.
Similar analysis of the spinal nucleus of the trigeminal nucleus shows high levels of
TdTomato/SYTO 13 co-localization in the lateral region of the brainstem. This region is
responsible for transducing painful information from the neck/head to the brain. There was also a
conservation of CCK expression in the spinal nucleus of the trigeminal nucleus from rostral to
caudal. These findings likely indicate a connection between CCK(+) neurons and pain
transduction. The nature of this relationship will be the topic of future research.
GABA Antibody Staining
Unexpectedly, immunohistochemical stains for the presence of the GABA
neurotransmitter did not yield strongly positive results in the spinal cord. Confocal analysis of
two different immunohistochemical stains (Anti-GABA and Anti-GAD65/67) indicate a very
low co-localization of CCK(+) neurons and GABA(+) cell bodies throughout the spinal cord.
These findings indicate that CCK(+) cell bodies in the sensory regions of the spinal cord do not
use the GABA neurotransmitter to communicate.
The same immunohistochemical analysis of the trigeminal nucleus did not yield such
definitive results. Rather, the Anti-GABA stain appears to indicate significant overlap of
red/green signal (TdTomato/Anti-GABA). These results are not supported by the Anti	
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GAD65/67 stain, which does not indicate an overlap between CCK(+) neurons and GABA(+)
neurons.
Further research into nature of CCK(+) neurons of both the spinal cord and trigeminal
nucleus is required to definitively identify the neurotransmitters these neurons use to
communicate. Preliminary results potentially indicate an interesting difference between the
methods of communication between CCK(+) neurons of the spinal cord and CCK(+) neurons of
the trigeminal nucleus. If these two distinct regions transduce painful information by different
means of communication, further research may indicate specific therapies that can be better
targeted toward the intended area of effect.
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FUTURE DIRECTIONS
The course of our research has opened up a number of avenues for future research. The
inconsistent results achieved when staining the spinal cord and trigeminal nucleus with AntiGABA and Anti-Gad65/67 immuno-fluorescent markers will be further investigated. Our
research team is currently working with a new mouse model, DLX5/6-CCK-TdTomato that will
allow us to definitively isolate CCK(+) neurons that use GABA as a neurotransmitter.
Further studies can be done to identify what neurotransmitter other CCK(+) neurons use
to communicate, such as the sensory neurons of the spinal cord and trigeminal nucleus. These
findings will generate a broader understanding of how these neurons contribute to the pain
pathways, and may just as well provide new targets for the administration of analgesic
medication.
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INTRODUCTION
Rationale
The mammalian vasculature system is a highly researched subject. Considering its
influence on the progression of disease, distribution of toxins/nutrients, deliverance of drugs,
etcetera, it’s no wonder so much time and money is dedicated to understanding and manipulating
the vasculature system. The variety of functions and dysfunctions of the vasculature system calls
for a wide breadth of research in order to understand it entirely. This research project aims to
further characterize the mammalian vasculature system.
Over the course of the research defined in the previous chapter, our lab team identified a
striking difference in the expression of CCK within the vasculature of the spinal cord and the
vasculature of the brain. Analysis through confocal microscopy indicated a high level of
CCK/TdTomato fluorescence in what appeared to be large vessels of the spinal cord. However,
when similar vessels were identified in the brain, no such fluorescence was found. As covered
previously, CCK is a paracrine peptide hormone, found in the gut, that signals the release of bile
and enzymatic proteins responsible for the breakdown of fatty foods [1]. Furthermore, CCK has
been implicated in the hyperanalgesic response to the disuse of opiate medications [2]. Thus,
CCK is involved in the modulation of painful signals from the spinal cord and trigeminal nucleus
to the sensory regions of the brain responsible for perceiving painful stimuli. Our observations
imply that CCK may also be an endocrine hormone; that is, a compound that travels through the
blood stream to effect distant organ systems. If so, this may be one mechanism by which CCK
modulates painful signals from the periphery.
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Previous Research into CCK and the Vasculature System
Research into the role of CCK as an endocrine protein has mostly focused on its role in
the breakdown of fatty foods. As such, CCK acts as a gallbladder constriction factor [3]. Recent
research evaluated the release of CCK as a neurotransmitter in the brain, and hypothesized that
overstimulation of CCK(+) neurons may result in elevated levels of CCK in the blood plasma [4].
However, this relationship has yet to be positively correlated, and there appears to be speciesspecific differences in the level of stimulation required to result in CCK in the plasma [4].
Interestingly, CCK has also been found as a relevant tumor growth factor in metastatic
tumors, particularly in the thyroid and adrenal glands [5]. As such, CCK has proven to be an
effective tumor indicator when present in plasma at higher than normal levels [5].
Research Objectives
The goal of this research experiment is to evaluate the noted expression of CCK in
vasculature of the spinal cord, but not the cortical tissue. Furthermore, our research aims to
identify which cells within the vascular tissue are expressing CCK. In order to identify these
cells, genetically-modified mice (CCK-Chr2) were perfused with a lipophilic endothelial cell
label (DiI) and analyzed through confocal microscopy in order to identify the cells responsible
for the fluorescence seen in the vasculature.
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RESEARCH QUESTION
Do blood vessels in the spinal cord and trigeminal nucleus differ in their expression of CCK?
MATERIALS & METHODS
Reagents
•   Isoflurane (B72J15B, Piramal)
•   Euthasol (200-071, Virbac)
•   PBS (P3813, Sigma-Aldrich)
•   Paraformaldehyde (HT501128-4L, Sigma-Aldrich)
•   SeaPlaque Brain Slice Agar (100262, MP Biomedicals)
•   Low Melting Point Agarose (50101, Lonza)
•   TEA Buffer (1610773, BioRad)
•   Aluminum Foil (obtained at retail store)
•   AAA Battery (obtained at retail store)
•   Superglue (obtained at retail store)
•   Triton X-100 (T8787, Sigma-Aldrich)
•   DiI C(18) Lipophilic Vasculature Stain (D3911, Thermofisher)
•   Vectashield Mounting Medium for Fluorescence (H-1400, Vector Laboratories)
•   Clear nail polish (obtained at retail store)
Equipment
•   26 ½ Gauge Needles
•   Three 10mL Syringes
•   Dissection Equipment
•   Plexi-glass Chamber
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•   Three-way stopcocks
•   50mL conical tubes
•   12-well plate
•   Soft-tip Paintbrush
•   Microscope slides
•   Standard glass coverslips (no. 1.5)
•   Vibratome (VT1000s, Leica)
•   Confocal Microscope (LSM 510 Meta, Zeiss)

REAGENT SETUP
2% Brain Slice Agarose
Add .4g Brain slice agar to 20mL of 1x TAE Buffer. Pour into petri dish. Store at 4 °C.

2% Low Melting Agarose
Use microwave to dissolve 0.2g in 10ml 1x TAE Buffer. Cool at RT and use immediately.

0.2% PBT
Mix 1mL Triton X-100 detergent with 500mL of PBS solution. Store at Room Temperature.

5% (wt/vol) Glucose
Dissolve 50g of glucose in 1000mL of MilliQ water. Filter through a 0.22-	
  µm filter.
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Diluent Stock
Mix PBS and 5% glucose at a ratio of 1:4.

DiI Stock Solution
Dissolve 100mg of DiI crystal in 16.7mL of 100% ethanol overnight with constant agitation.
Store at room temperature in the dark. Keep covered with aluminum foil at all times.

DiI Work Solution
Immediately before use, add 200µL of DiI stock solution to 10mL of diluent. Quickly shake to
mix.
PROCEDURES
Cardiac Perfusion
1.   Fill the three syringes with perfusion fluids.
a.   One with 10mL PBS
b.   One with 10mL PFA
c.   One with 10mL DiI work solution
2.   Back flow the perfusion line first with PFA, then DiI, then PBS to ensure no air is in the
line
3.   Saturate plexi-glass chamber with Isoflurane
a.   Wet tissue paper in 50mL conical tube with Isoflurane and place in chamber
4.   Prepare syringe with Euthasol
a.   .05mL for female mice; .07mL for male mice
5.   Place mouse in Isoflurane chamber until breathing is slow
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6.   Remove mouse by grasping the neck fur; place on lab mat and check paw reflex by
pinching any of the paws
a.   If the animal reacts, anesthetize further; if not, proceed.
7.   Inject the mouse intraperitoneal with Euthasol and place on dissecting tray; hold the
mouse in place with its tail until euthanasia has occurred
8.   Pin the mouse through its four paws, leaving the thoracic cavity exposed
9.   Open the thoracic cavity to expose the heart by first cutting through the skin, then
through the viscera
10.  Pull ribcage back and ensure the heart is fully accessible
11.  Insert 26 ½ gauge needle into the left ventricle while supporting with hemostat; once
punctured, clamp with hemostat
12.  Cut right atrium with scissors and begin perfusion (at slowest possible rate)
13.  Perfuse with PBS until perfusate runs clear (at least 10 minutes)
a.   Intestines and liver will turn a clear color, indicating a successful perfusion
b.   All perfusion fluids should be administered at ~1mL/minute
14.  Switch to DiI work solution and perfuse for 10 minutes
15.  Switch to 4% PFA and perfuse for 10 minutes
16.  Collect brain and spinal cord tissue and place in 4% PFA overnight at 4 °C to complete
fixation
17.  Dispose of mouse accordingly
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Spinal Cord Prep for Slicing
5.   Tear off thin strip of aluminum foil approx. 4 inches long
6.   Roll aluminum foil around AAA battery, leaving positive terminal exposed
a.   Fold foil around the bottom of the battery and press against lab bench to ensure a
closed bottom
7.   Remove battery from foil; fill foil cylinder with 2% low melting agarose, leaving approx.
1cm for displacement
8.   Using forceps, embed spinal cord lengthwise in liquid agarose and allow to cool,
ensuring the tissue remains upright and parallel to cylinder walls
Tissue Slicing
14.  Prepare Vibratome with PFA well
15.  Soak razorblade in ethanol for 2 minutes
16.  Using forceps, evenly attach blade to PFA-specific mount and screw into place
17.  Cut brain slice agarose into two rectangles, mounting a base and backbone to secure
animal tissue in Vibratome well
a.   Mount with the minimum amount of superglue to ensure agarose is in place, but
not overly saturated
18.  Prepare tissue for sectioning
a.   Trim brain with razor to ensure a flat surface for mounting
b.   Remove agarose-embedded spinal cord and ensure a flat surface for mounting
19.  Place a conservative amount of superglue on top of the base piece of agarose
20.  Using a spatula, add brain or spinal cord flush with the back piece of agarose, directly
centered on base agarose
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21.  Fill well to the brim with PBS, making sure the blade and tissue are submerged
22.  Set the Vibratome to 100µm per slice
23.  Move blade close to the top of the tissue, set start position
24.  Slice through the top of the tissue, setting the endpoint within the back piece of agarose
25.  Hit the start button to automatically slice 100 microns below last cut
26.  Save desired slices in 12-well plate with 1mL of PBS in each well
a.   Add slices to wells using soft-tip paintbrush
i.   Approx. 3-4 brain slices per well
ii.   Approx. 4-5 spinal cord slices per well
SYTO 13 Staining
All washes are 10 minutes long with 1mL of wash per well; washes and incubation take place on
rotor at low speed (constant agitation)
8.   Wash slices 2 times with 1mL 0.2% PBT
a.   Washes are done by discarding liquid into waste and adding 1mL of wash
b.   Always cover the 12-well plate with aluminum foil to prevent light exposure
9.   After second wash, remove remaining PBT
10.  Add 500µL 0.2% PBT
11.  Add SYTO 13 work solution, allowing for 500nM final concentration
12.  Incubate for 1 hour at room temperature
13.  Wash 3 times with 0.2% PBT
14.  Mount slices on microscope slides
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Immunohistochemical Staining Protocol
All washes are 10 minutes long with 1mL of wash per well; washes, incubations, and washes
take place on rotor at low speed (constant agitation)
17.  Add 1mL of PBS to each well of a 12-well plate
18.  With soft-tip paintbrush, gently add tissue slices to wells and sink to the bottom
19.  Wash slices 1 time in PBS and 2 times in 0.2% PBT
20.  Block for 2 hours at room temperature in 1mL 5% BSA/PBT per well
a.   5% BSA/PBT made by dissolving .6g BSA in 12mL of 0.2% PBT
21.  Leave slices in blocking buffer overnight at 4 °C with constant agitation
a.   Using a moist Kimwipe and Parafilm, create a humidity chamber by taping the
Kimwipe to the roof of the 12-well plate and ensuring a good seal
22.  After 36 hours, remove 12-well plate from cold room
23.  Wash slices 3 times in PBT
24.  Add 500 µL 5% BSA/PBT per well
25.  Add primary antibody at room temperature and block for 1 hour
a.   1µL per well for Anti-GABA (~1:500 dilution)
b.   2.5µL per well for Anti-GAD65/67 (~1:200 dilution)
26.  Leave primary antibody on shaker at 4 °C for 36 hours
a.   Create humidity chamber
27.  Wash 3 times in 0.2% PBT
28.  Add 500µL 0.2% PBT per wel
29.  Add 2.5µL of secondary antibody per well (~1:200 dilution)
a.   Goat Anti-Mouse for Anti-GABA
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b.   Donkey Anti-Rabbit for Anti-GAD65/67
30.  Leave at room temperature for 3 hours with constant agitation
31.  Wash 3 times 0.2% PBT; 1 time PBS
32.  Mount slices on microscope slides
Microscope Mounting
8.   After mounting slices with soft-tip paintbrush, remove excess PBS from slide with
Kimwipe
9.   Add Vectashield drop-wise to ensure all tissue slices are protected from fading
10.  Mount coverslip and label slide
11.  Wrap in aluminum foil to protect from light exposure
12.  Store at 4 °C for 30 minutes
13.  Cover edges of coverslip with a thin layer of clear nail polish to increase adhesion and
protect tissue from dehydration
14.  Store at 4 °C in black box to prevent light exposure
Confocal Microscopy
6.   Setup LSM 510 Meta microscope for multi-channel imaging
a.   For DiI collection, use 488nm excitation and collect using a custom filter for
wavelengths between 527-540nm
b.   For TdTomato collection, use 543nm excitation and collect using LP 560
7.   Use on-screen command to select the desired objective
8.   Set pinholes for each channel to 1
9.   Isolate area of interest in the optical objective
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10.  Select ‘Find’, to collect an image
a.   adjust offset/gain as needed

	
  
	
  

	
  

33	
  

RESULTS
Through the use of confocal microscopy, extensive segments of mouse vasculature were
identified in the spinal cord and cortical tissue. Spinal cord slices of CCK-Chr2 mice indicate
very strong green fluorescence (Chr2) throughout the apparent vasculature of the spinal cord, but
not cortical tissue (Figure 1).
Analysis of DiI-stained tissue in both the spinal cord and cortical areas indicate
successful vasculature staining. Vasculature of the brain indicates a strong co-localization of
Chr2 expression and DiI labelling (Figure 2). Images of the spinal cord show moderate, but
incomplete Chr2 co-localization with DiI-stained vascular tissue (Figure 3).

Figure 1. Vasculature of cortical tissue and spinal cord tissue
(Left) Cortical vasculature (amygdala). Chr2 expression (green) indicates the
presence of CCK. The boxed region indicates what appears to be a large cortical
vessel.
(Right) Spinal cord vasculature. Chr2 expression (green) indicates the presence of
CCK. Large vascular tissue appears to express CCK, as well as surrounding
neuronal tissue.
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Figure 2. Chr2/DiI Co-localization in cortical tissue (striatum)
(Left) Chr2 label (green) indicates CCK expression. (Middle) DiI stain (red)
indicates vasculature. (Right) Co-localization of Chr2 and DiI (orange)
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Figure 3. Chr2/DiI expression in spinal cord
(Left) Chr2 label (green) indicates CCK expression. (Middle) DiI stain (red) indicates vasculature.
(Right) Co-localization of Chr2 and DiI images
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DISCUSSION
CCK Expression in Vasculature
The lipophilic DiI stain worked very well for labelling the vasculature of both the spinal
cord and brain. Co-localization analysis of Chr2 labelling (indicating CCK expression) and DiI
staining (indicating vasculature) demonstrated very unexpected results from what was seen in the
initial observations. Initially, CCK expression appeared to be co-localized with the vasculature of
the spinal cord, but not of the cortical tissue. The results of this study indicate a very high level
of CCK/DiI co-localization in cortical tissue, but only low to moderate levels of co-localization
in the spinal cord. A number of factors may contribute to this unexpected result. Firstly, the
emission spectra for both DiI and Chr2 are difficult to separate. It is likely that interference
between the signals may produce images in which there appears to be signal where it does not
actually exist. Secondly, the region of analysis may also be a confound the results. In the analysis
of cortical tissue, there are small circular cell bodies that protrude from the vascular tissue. These
are believed to be pericytes, which help maintain the structure of capillary vasculature. In images
of the spinal cord, the vasculature appears to lack these pericytes, indicating that the image is
taken of a vein or artery. Thus, it is possible that CCK-expression in vascular tissue is present
only in the capillary beds. Further research is required before any conclusions about CCKexpression in vascular tissue can be made.
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FUTURE DIRECTIONS
Although analysis of CCK-expression in the vasculature of the spinal cord and cortical
tissue presented confounding data, future research into capillary-dependent CCK expression and
the communication of CCK (+) neurons and blood vessels are still viable pursuits. The
unmistakable connections made between CCK (+) terminal buttons and vasculature walls may be
an important aspect in the control of blood flow throughout the central nervous system. More
research into these connections is required to better understand how CCK (+) neurons function in
the mammalian nervous system.
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APPENDIX
Article Published in UNH’s Inquiry Journal

Pain Perception: Investigating Links
Between Pain Transmission and CCK(+)
Neurons, with Regard to the Opioid
Crisis
—Sumeet Panesar and Zachary Tepper
With dependence upon opioids, such as codeine, morphine, and heroin, steadily increasing
amongst the American public, the withdrawal symptoms associated with disuse are receiving
much more attention. From its regular appearance in pop culture songs to serving as the
underlying theme in many independent films, opioid addiction and withdrawal has become part
of many Americans’ everyday life. Often, patients experiencing the withdrawal symptoms of
opioid dependence complain of the devastating impact of hyperalgesia (Angst, Koppert, Pahl,
Clark, & Schmelz, 2003). Hyperalgesia is a heightened sensitivity to pain, and it is very common
in those who quit using opioid medications. Opioid dependence has increased in tandem with
opioid prescription rates, and it’s only right that research into the complicated processes of
addiction and withdrawal keep up with the high usage levels.
Unfortunately, scientific understanding of
the complicated actions of opioid painkillers
and the implications of their chronic use is
lacking. Our research was directed by the
interests of our neuroscience lab mentor, Dr.
Arturo Andrade, who is an avid researcher in
the field of pain perception. Our project,
funded through the Summer Undergraduate
Research Fellowship (SURF) program at the
University of New Hampshire, aimed to
identify particular neurons, or cells of the
nervous system, that are involved with the
withdrawal symptoms of opioid dependence.
More specifically, our research aimed to
The authors analyzing brain slices using the confocal
find, or localize, neurons in the sensory
microscope. Sumeet (left) Zach (right).
pathways that express a protein called
cholecystokinin (CCK), which has been
associated with the hypersensitivity to pain that is symptomatic of opiate withdrawal (Angst,
Koppert, Pahl, Clark, & Schmelz, 2003). CCK is a protein; as such, the blueprint for producing it
resides in the genetic code. Most cells don’t utilize this part of their genetic code, and thus most
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cells don’t make, or express, CCK. By targeting the CCK protein, we hoped to isolate those
particular cells that are responsible for the hyperalgesia that so commonly occurs during opiate
withdrawal. We aimed to provide insight into the biological mechanism(s) responsible for
opioid-induced hyperalgesia by locating the distribution of these neurons throughout the central
nervous system, and then beginning to characterize their function. These findings may serve to
undermine high levels of opioid prescriptions or suggest alternative drug therapies for combating
hyperalgesia.

CCK and the Pain Perception Mechanism of the Brain and Spinal
Cord
The protein cholecystokinin (CCK) is an enzyme that was first identified in the small intestine of
mammals. In the gut, CCK plays a role in signaling the release of bile from the gallbladder and
digestive enzymes from the pancreas. In this way, CCK acts as a precursor to the breakdown of
fat and protein. Current evidence, which has directly influenced the direction of our research,
indicates that CCK also plays a role in the experience of painful sensations (Wiesenfeld-Hallin,
Xu, & Hokfelt, 2002).
The central nervous system, consisting of the brain and spinal cord, plays a necessary role in
making sure that exposure to pain is perceived correctly. In order to do so, the nervous system is
organized in a very particular manner. The spinal cord can be divided into two sections, ventral
(front/anterior) and dorsal (back/posterior). The ventral portion is commonly referred to as the
“motor” area because it is home to the neurons that are responsible for controlling our muscles.
The ventral area allows us to move our bodies how we want to. The dorsal portion of the nervous
system is known as the “sensory” area because it receives information from the periphery
(anywhere outside the brain and spinal cord) and transmits it to the brain so that we can perceive
it. If an individual were to step on a pin, for example, it is the responsibility of the dorsal area of
the spinal cord to relay that information to the brain to be perceived as pain. However, the spinal
cord is limited in that it receives information only from below the neck.
In order to perceive information from the neck and above, we rely on an area of the brainstem
called the sensory nuclei of the trigeminal nucleus. The trigeminal nucleus consists of three
clusters of neurons in the brainstem. Two of these clusters are dedicated solely to sensory
perception, while the third is split between sensory perception and motor control. The brainstem
is different from the spinal cord; it can be considered a transitional point between the spinal cord
and the brain itself. Instead of being organized by ventral and dorsal areas, the brain stem is
organized from medial (central) to lateral (outer). The sensory areas of the brainstem are found in
the outermost area. A cross-section of the brain stem would look like the letter “O.” The outer
ring of the “O” would be the sensory region and the inner portion would be the motor region.
Visualizing the spinal cord and brainstem as a stack of Os, the sensory pathways travel vertically
through the outer portion of the Os. Thus, sensory information from the neck, face, and head
(including pain) must be transmitted through the outermost cell bodies of the trigeminal nucleus.
Research into the sensation and perception of pain has highlighted that neurons that express CCK
(hereon termed CCK(+) neurons) play an important role in the acute tolerance that is observed in
response to analgesic opiate medicine (Kissin, Bright, & Bradley, 2000). In other words, CCK(+)
neurons in the sensory areas of the central nervous system are responsible for making a patient
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need larger and larger doses of opiates in order to relieve the same amount of pain. Before
delving into how to tackle such an issue, a thorough understanding of how neurons work and
how they communicate is needed.
Neurons in the body communicate through neurotransmitters, which are chemical compounds
transmitted from one neuron to another. In this way, information passes throughout the nervous
system. CCK(+) neurons in the central nervous system belong to one of two main subcategories,
depending on which neurotransmitter they use to relay information: glutamatergic or GABAergic
(GABA is an acronym for gamma aminobutyric acid). For our experiment, we focused solely on
the GABA neurotransmitter.
A neurotransmitter is either excitatory or inhibitory. Excitatory neurotransmitters increase the
likelihood that a neuron will continue to pass along information. Inhibitory neurotransmitters
decrease this likelihood. Glutamate is the most common excitatory neurotransmitter in the
central nervous system, while GABA is the most common inhibitory neurotransmitter in the
nervous system. The goal of our research was to localize CCK(+) cell bodies within the sensory
pathways and categorize them as either excitatory or inhibitory; we also aimed to identify the
specific neurotransmitters that these neurons used to communicate.

Transgenic Mice Background and Staining Techniques
In order to localize, or find, these neurons, we acquired two separate breeds of genetically
modified mice. When bred together, the heterozygous offspring of these two breeds contained a
label in its genetic code. This label, known as TdTomato, emits a bright red light under proper
conditions. The genetic modifications of these mice ensured that the TdTomato label was paired
with the expression of CCK. That way, any cell that expressed CCK would also express
TdTomato, and would be identifiable by its red color when viewed under a confocal microscope.
Unfortunately, CCK is found throughout the entire anatomy of the neurons that express it, and
not just the cell bodies. Thus, although the cell bodies themselves will have a red label, so will
the long axons and dendrites that project from the cell body. This creates some confusion,
because neurons are extraordinarily close together, which may cause one cell’s dendrites, axons,
and cell body to overlap with another cell’s dendrites, axons, and cell body. As a result, it
becomes very difficult to differentiate which cells truly express CCK and which do not. While
TdTomato helped identify the general area within the spinal cord and trigeminal nucleus where
CCK(+) could be found, we needed to be more specific.
In order to identify which neurons were truly expressing CCK, we used the fluorescer SYTO 13.
A fluorescer is a molecule that emits light under the proper conditions. We applied SYTO 13
through a specific staining process. SYTO 13 is useful because it enters the cell body and binds
to the nucleic acids of DNA and RNA. SYTO 13 produces a bright green light, indicating the
presence of a neuron’s cell body. Thus, any CCK(+) cell body would be labelled by the red
TdTomato as well as the green SYTO 13, producing an identifiable yellow/orange color. Within
the sensory region of the spinal cord and trigeminal nucleus, we were able to distinguish clearly
the yellow/orange color under the confocal microscope.
After we localized the CCK(+) neurons with the yellow/orange color, we used antibody staining
techniques to indicate the presence or absence of the GABA neurotransmitter in the CCK(+) cell
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bodies. Antibody staining uses immune-system proteins to identify a specified target. Our target
was GABA, and we used an antibody known as Anti-GAD 65/67 to indicate its presence. Under
the confocal microscope, both SYTO 13 and the Anti-GAD stains emit a green fluorescence.
Therefore, separate samples were used to stain with SYTO 13 and Anti-Gad. Staining for
GABA, if both the spinal cord and trigeminal nucleus demonstrated a positive result, there would
be evidence that CCK(+) neurons in the sensory regions of the pain pathway communicate
through the use of GABA-mediated inhibition. This information could guide future studies into
the biological and electrical properties of the CCK(+) neurons, and thus inspire insight into the
behavioral implications involved in the sensation of pain.

Mysteries Behind the Fluorescing Light Revealed
Through the use of confocal microscopy, we identified the presence of CCK(+) neurons in the
sensory areas of the spinal cord and trigeminal nucleus (Figure 1). The red fluorescence from
TdTomato indicated the presence of CCK. Green SYTO 13 fluorescence indicated the presence
of neuronal cell bodies. Therefore, the co-presence of the red TdTomato and green SYTO 13
emissions, as shown by a yellow/orange color, indicated a CCK(+) neuronal cell body.

Figure 1: The trigeminal nucleus (left) shows yellow/orange florescence in the sensory region when stained
with SYTO 13. The spinal cord (right) also shows a yellow/orange florescence in the sensory region
indicating CCK(+) neurons.
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We were curious to see if there were any differences in the amount of CCK(+)
neurons in varying regions of the spinal cord, so we examined the lumbar,
thoracic, and cervical regions (Figure 2). Individual slices from each of the
three regions demonstrated an equal amount of red fluorescence throughout the
sensory areas of the spinal cord. When stained with SYTO 13, there was also a
bright green fluorescence throughout all of the gray matter (neural tissue where
neuronal cell bodies are located). The images indicate an overlap of the
red/green fluorescence (as indicated by a yellow/orange color) in the dorsal
areas of the sensory regions, specifically lamina (layers) II/III (Figure 1). The
lamina II/III of the spinal cord, also known as the substantia gelatinosa, is
involved with the transmission of painful signals from the body, where they
occur, to the brain, where they are perceived (Cervero & Iggo, 1980). This
finding supports our hypothesis that CCK(+) neurons reside in the most dorsal
areas of the sensory region of the spinal cord. This finding also supports the
hypothesis that CCK(+) neurons are involved with the transmission of painful
signals from the body. After analyzing the spinal cord, our attention shifted
toward the trigeminal nucleus in an attempt to localize CCK(+) neurons there.
The neuronal cell bodies in the trigeminal nucleus are responsible for the
perception of pain from the neck and head (Wilcox et al., 2015). The caudal
(lower) portion of the trigeminal nucleus contains a cluster of cells known as
the spinal nucleus of the trigeminal nerve. This cluster of cells is responsible
for the transmission of painful signals, as opposed to other sensory information
(such as touch and pressure) that is also carried through the trigeminal nucleus
(Wilcox et al., 2015).

Figure 2: Image
of a dissected
mouse spinal
cord. From top
to bottom the
sections are
cervical,
thoracic, and
lumbar.

By staining the trigeminal nucleus with SYTO 13 we were able to see a bright
yellow/orange fluorescence in the lateral, or outer, region of the brain stem.
The trigeminal nucleus sample contained both rostral and caudal (higher and lower, respectively)
slices. We observed an increased amount of yellow/orange fluorescence in the rostral slices
compared to the caudal slices, meaning there are more CCK(+) cell bodies in the higher sections
of the trigeminal nucleus.
These findings support our hypothesis that CCK(+) neurons are involved in the perception of
pain from the neck and head. We then turned to additional immunostains to determine whether
co-localization actually existed within the CCK(+) cells.
Anti-GAD65/67 and Anti-GABA immunostains, which fluoresce bright green, demonstrated
fluorescence throughout the gray and white matter of both the spinal cord and trigeminal nucleus
(Figure 3). Primary and secondary antibody staining of the trigeminal nucleus slices showed
many red fluorescent neurons, fewer green fluorescent neurons, and very few yellow/orange
fluorescent neurons.
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Figure 3: The trigeminal nucleus (left) with the Anti-GABA stain shows a mix of red, green, and
yellow/orange neurons. The spinal cord (right) with the Anti-GABA stain shows a similar mix of neuronal
fluorescence.

Thus, in both the spinal cord and trigeminal nucleus, there was very little co-localization of CCK
and GABA. Rather, CCK was generally confined to the sensory regions, while GABA was
spread throughout. We identified individual GABAergic neurons in the sensory regions, but
there was minimal overlap between GABA and CCK. This does not support our hypothesis that
CCK(+) neurons act through the transmission of GABA, but does not eliminate the possibility
that these neurons are inhibitory. Although GABA is the most common inhibitory
neurotransmitter in the central nervous system, there are numerous other inhibitory chemicals
that may linked CCK(+) neurons or to pain inhibition (Beato & Nistri, 1998; Surmeier, Ding,
Day, Wang, & Shen, 2007). Future experiments need to identify the exact neurotransmitter(s)
that is/are released from CCK(+) neurons, as well as the effects that these neurotransmitters have
on the rest of the central nervous system.

Final Thoughts and Future Endeavors
Our research has progressed quite far given the time frame of our experiments. Although we
answered several questions throughout the early experimentation phase, many more uncertainties
arose that will need further clarification. Localizing CCK(+) neurons is merely a scratch on the
surface. Our research will not stop here and will continue for many semesters to come.
At the time we published this article, we had spent only a couple of months compiling data on
this research project. In that time, we took away much more than expected. Throughout the
project, we were able to apply our in-class knowledge and have many intellectually stimulating
discussions; this experience will benefit us for years to come. For Sumeet, who plans to pursue a
career in dental medicine, this experience has been invaluable, as he will be relied upon for his
acute awareness and understanding of neck/head pain. This experience has also been
advantageous to Zachary, who intends to practice medicine for the United States military, where
an intimate understanding of the central nervous system will serve him well.
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With regard to the overall aim of the project, we hope that by building upon our current research
we eventually will be able to understand the underlying mechanisms that contribute to pain
perception and modulation within the CCK(+) neurons. With this new information, it would be
easier to specifically target the mechanisms that contribute to the hyperalgesic effects of opioid
withdrawal and to alleviate these symptoms altogether.
There are many individuals who deserve our highest regards; without them our experiment and
research could never have begun. We would like to thank first and foremost our lab mentor, Dr.
Arturo Andrade, for helping originate the idea and aid in the experimental setup. We would also
like to thank the Hamel Center for Undergraduate Research for giving us the opportunity to
receive a Summer Undergraduate Research Fellowship to work in our lab over the summer.
Finally, we would like to thank our families for their continuous support and encouragement
throughout the duration of the grant.
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